The Fetal Brain in Fetuses with Orofacial Abnormalities

2017 ◽  
pp. 131-141
Author(s):  
Gustavo Malinger
Keyword(s):  
Fetal Brain

The role of placental growth factor in regulating fetal brain vascular development

2014 ◽  
Author(s):  
Matthew T Ratsep ◽  
Bruno Zavan ◽  
Nicki Peterson ◽  
Leandra Tolusso ◽  
Vanessa Kay ◽  
...  
Keyword(s):  
Growth Factor ◽  
Vascular Development ◽  
Fetal Brain ◽  
Placental Growth Factor

Fetal Brain Activity in Pregnancy of Women with Type 1 Diabetes Mellitus

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1402-P
Author(s):  
ELLEN FEHLERT ◽  
FRANZISKA SCHLEGER ◽  
KATARZYNA LINDER ◽  
MARTIN HENI ◽  
HANS-ULRICH HAERING ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Brain Activity ◽  
Fetal Brain ◽  
In Pregnancy

CEREBRAL PALSY:A CLINICAL OVERVIEW

2020 ◽  
Vol 3 (1) ◽  
pp. 54-59
Author(s):  
Nargiza Ergasheva ◽  
◽  
Sardor Anorboev ◽  
Gavkhar Kendjaeva ◽  
Keyword(s):  
Brain Area ◽  
Fetal Brain ◽  
Clinical History ◽  
Screening Tests ◽  
Spastic Diplegia ◽  
Team Approach ◽  
Birth Process ◽  
Increased Risk ◽  
Spastic Quadriplegia ◽  
Magnetic Resonance Imaging Mri

Cerebral palsy (CP) is a disorder characterized by abnormal tone, posture and movement. The incidence of CP is 2–4 per 1,000 live births in the world. Prematurityand low birth weight are important risk factors for CP; however, multiple other factors have been associated with an increased risk for CP, including maternal infections and diseases, and abnormal birth process. In most cases of CP the initial injury to the brain occurs during early fetal brain development, later a brain area that is injured cannot function properly in the future. CP is classified clinically based on the predominant motor syndrome—spastic hemiplegia, spastic diplegia, spastic quadriplegia, ataxic and dyskinetic cerebral palsies. The diagnosis of CPis based on a combination of clinical history, use of standardized neuromotor assessment and findings on magnetic resonance imaging (MRI). If there is a suspicionof genetic or inborn metabolic disorders, screening tests should be provided additionally. Because CP is associated with multiple associated and secondary medical conditions, its management requires a multidisciplinary team approach

Effects of in utero endotoxemia on the ovine fetal brain A model for schizophrenia

10.2741/e588 ◽  
2012 ◽  
Vol E4 (8) ◽  
pp. 2745-2753 ◽  
Author(s):  
Boris W Kramer
Keyword(s):  
Fetal Brain ◽  
In Utero ◽  
Ovine Fetal

Embolism of Fetal Brain Tissue to the Lungs and the Placenta

1997 ◽  
Vol 17 (1) ◽  
pp. 159-167 ◽  
Author(s):  
Rebecca Baergen ◽  
Manuel Castillo ◽  
Blesilda Mario-Singh ◽  
Arthur Stehly ◽  
Kurt Benirschke
Keyword(s):  
Brain Tissue ◽  
Fetal Brain

Statins and implications for fetal brain sparing during hypoxia

2013 ◽  
pp. 42-44
Author(s):  
Andrew Kane ◽  
Emilio Herrera ◽  
Avnesh Thakor ◽  
Dino Giussani
Keyword(s):  
Fetal Brain

New normal range of fetal cavum septum pellucidum in the second trimester of gestation

2020 ◽  
Author(s):  
M.V. Medvedev, O.I. Kozlova, À.Yu. Romanova
Keyword(s):  
Brain Development ◽  
Reference Range ◽  
Fetal Brain ◽  
Septum Pellucidum ◽  
Second Trimester ◽  
Normal Range ◽  
Cavum Septum Pellucidum ◽  
New Normal ◽  
Biparietal Diameter ◽  
Fetal Brain Development

Fetal brain was retrospectively evaluated in 418 normal fetuses at 16–28 weeks of gestation. The multiplanar mode to obtain the axial cerebral plane and measured the width of the cavum septum pellucidum (CSP) and biparietal diameter (BD). All measurements of CSP were done from as the widest diameter across both borders in an inter-to inter fashion. The CSP width is increasing at second trimester of gestation. Normal range plotted on the reference range (mean, 5th and 95th percentiles) of fetal width CSP by measuring of its size may be useful for assessment of fetal brain development in the second trimester of gestation.

Sign in / Sign up

Export Citation Format

Share Document